Shopping Cart
Remove All
Your shopping cart is currently empty
VEGFR-2-IN-43 (compound 16) is an orally active VEGFR2 inhibitor with an IC50 of 39.91 μM, and is suitable for research on wet age-related macular degeneration (w-AMD).
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Backorder | Backorder | |
| 50 mg | Inquiry | Backorder | Backorder |
| Description | VEGFR-2-IN-43 (compound 16) is an orally active VEGFR2 inhibitor with an IC50 of 39.91 μM, and is suitable for research on wet age-related macular degeneration (w-AMD). |
| Targets&IC50 | VEGFR2:39.91 μM |
| In vitro | VEGFR-2-IN-43 (compound 16) exhibits a mild inhibitory effect on LX-2 cell proliferation and a significant inhibitory effect on the proliferation of BaF3-Tel-VEGFR2 cells when administered at concentrations ranging from 0-50 μM over 72 hours. Additionally, VEGFR-2-IN-43 shows a concentration-dependent inhibition of VEGFR2 phosphorylation in HUVEC cells at 0-10 μM for 48 hours. The compound also demonstrates notable plasma stability and moderate liver microsomal stability at a concentration of 1 μM within a 0-120 minute timeframe. |
| In vivo | VEGFR-2-IN-43 (compound 16), when administered to ICR mice at doses of 2/10 mg/kg either intravenously or orally, demonstrates an acceptable oral bioavailability of 20.2% (F = 20.2%). |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.